Dr. Sonia Skarlatos and the National Heart, Lung, and Blood institute translational research and resource programs.

about

Dr. Sonia Skarlatos-leader, colleague, and friend: from vascular biology to gene therapy and the Cardiovascular Cell Therapy research network.

P2860

Q37272842-6FE4AC23-A665-4FA9-A186-551F9F436E23

P2860

Dr. Sonia Skarlatos and the National Heart, Lung, and Blood institute translational research and resource programs.

Item

http://www.wikidata.org/entity/Q37272874

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Dr. Sonia Skarlatos and the Na ...... esearch and resource programs.

@en

Dr. Sonia Skarlatos and the Na ...... esearch and resource programs.

@nl

type

Item

label

Dr. Sonia Skarlatos and the Na ...... esearch and resource programs.

@en

Dr. Sonia Skarlatos and the Na ...... esearch and resource programs.

@nl

prefLabel

Dr. Sonia Skarlatos and the Na ...... esearch and resource programs.

@en

Dr. Sonia Skarlatos and the Na ...... esearch and resource programs.

@nl

P1476

Dr. Sonia Skarlatos and the Na ...... esearch and resource programs.

@en

P2093

Cheryl L McDonald

http://www.w3.org/2001/XMLSchema#string

P2860

Support for cardiovascular cell therapy research at the National Heart, Lung, and Blood Institute

Vector production in an academic environment: a tool to assess production costs

Development of a network to test strategies in cardiovascular cell delivery: the NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN).

Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.

Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.

Oversight and management of a cell therapy clinical trial network: experience and lessons learned

Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Ne

Center for fetal monkey gene transfer for heart, lung, and blood diseases: an NHLBI resource for the gene therapy community.

Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial

New programs for gene- and cell-based therapies at NHLBI.

P304

899-905

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/HUM.2013.2511

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24164237

http://www.w3.org/2001/XMLSchema#string

P932

3815047

http://www.w3.org/2001/XMLSchema#string

Dr. Sonia Skarlatos and the National Heart, Lung, and Blood institute translational research and resource programs.

about

P2860

P2860

Dr. Sonia Skarlatos and the National Heart, Lung, and Blood institute translational research and resource programs.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932